DR. FAIKA KHAN CEO OF CITY DOCTOR PVT. LTD. AND MR ALI J HASHMAT CEO OF CURE PARTNERS PVT. LTD. ANNOUNCEMENT OF FULL ACQUISITION OF “THE MEDICAL LABORATORY PVT. LTD.” DBA ZEENAT LABORATORIES

NEW YORK, Oct. 27, 2022 /PRNewswire/ — Dr Faika Khan CEO of CITY DOCTOR PVT. LTD. and Mr. Ali J Hashmat of CURE PARTNERS PVT. LTD. announced 100% acquisition of “The Medical laboratory Pvt. Ltd.” Doing Businesses as (DBA) “ZEENAT LAB“, one of the most renowned lab with a history of over 50 plus years serving the community. ZEENAT LAB is a pioneer in the field of diagnostics and is best known for its broad spectrum of clinical laboratory testing is designed to provide accurate and meaningful results.

Dr. Faika khan and Mr. Ali J Hashmat, embraced the opportunity to further develop ZEENAT LAB and take the legacy of Dr. Zeenat and Dr. Mubashar Hussain. This acquisition will leverage expertise in advanced clinical settings, technology, customer service, training, support combined with the intelligent design of the laboratory system and ongoing development of State of the Art software by Cure Partners. “By investing in this venture we are investing in the future of Pakistan and continuing our commitment to provide innovative solutions for its customers,” said Dr. Faika Khan and Ali J Hashmat directors and founders of City Doctors and Cure Partners.

Dr. Faika Khan is a founder and president of City Doctor and UrgentWay. She is a board certified faculty member of New York University and NorthWell University hospital and recognized among the Top Doctors in America. Mr. Ali J Hashmat is a founder of CureMD, NaVetor, UrgentWay and City Doctor.

CONTACT: Dr. Arsalan Khan

CONTACT: Mr. Shan Khan, CPA

COMPANY: City Doctor

COMPANY: UrgentWay

TEL: +92-42-3893-9145

TEL: +1 (201) 401-4805 

 

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PR Newswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, PR Newswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.